Shuyi Zhou Selected Research

Non-alcoholic Fatty Liver Disease

1/2022

GLP-1 RAs and SGLT-2 Inhibitors for Insulin Resistance in Nonalcoholic Fatty Liver Disease: Systematic Review and Network Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuyi Zhou Research Topics

Disease

7	Neoplasms (Cancer) 01/2024 - 01/2019
2	Adenocarcinoma of Lung 01/2022 - 01/2019
1	Obesity 02/2024
1	Pediatric Obesity 02/2024
1	Colorectal Neoplasms (Colorectal Cancer) 10/2023
1	Genomic Instability 10/2023
1	monomelic Amyotrophy 01/2022
1	Insulin Resistance 01/2022
1	Disease Progression 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Multiple Organ Failure (MODS) 08/2021
1	Pancreatitis 08/2021
1	Inflammation (Inflammations) 04/2021
1	Central Cord Syndrome 07/2020
1	Pain (Aches) 01/2020
1	Plantar Fasciitis 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 04/2019
1	Breast Neoplasms (Breast Cancer) 04/2019
1	Diarrhea 01/2019
1	Scoliosis 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Clostridium Infections 01/2018
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018
1	Epilepsy (Aura) 01/2016
1	Drug Resistant Epilepsy 01/2016

Drug/Important Bio-Agent (IBA)

2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023 - 10/2023
1	Indicators and Reagents (Reagents)IBA 02/2024
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024
1	Photosensitizing Agents (Photosensitizers)IBA 01/2024
1	Poly Adenosine Diphosphate RiboseIBA 12/2023
1	Therapeutic UsesIBA 10/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	SodiumIBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 04/2021
1	Tight Junction ProteinsIBA 04/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 04/2019
1	Sirolimus (Rapamycin)FDA Link 04/2019
1	CytokinesIBA 04/2019
1	Chloroquine (Aralen)FDA LinkGeneric 04/2019
1	phosphoribosylaminoimidazole carboxylaseIBA 04/2019
1	EnzymesIBA 04/2019
1	purineIBA 04/2019
1	TropomyosinIBA 01/2019
1	glycylglutamineIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	pepstatin (pepstatin A)IBA 01/2016

Therapy/Procedure

5	Therapeutics 01/2024 - 01/2016
1	Photochemotherapy (Photodynamic Therapy) 01/2024
1	Drug Therapy (Chemotherapy) 10/2023
1	Diskectomy (Discectomy) 01/2022
1	Surgical Decompression 07/2020
1	Extracorporeal Shockwave Therapy 01/2020
1	Photothermal Therapy 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Traction 01/2019